Effects of curcumin, a major ingredient of turmeric, were tested on the function of the a 7 -subunit of the human nicotinic acetylcholine (a 7 -nACh) receptor expressed in Xenopus oocytes and on nociception in mouse models of tonic and visceral pain. Curcumin caused a significant potentiation of currents induced by acetylcholine (ACh; 100 mM) with an EC 50 value of 0.2 mM. The effect of curcumin was not dependent on the activation of G-proteins and protein kinases and did not involve Ca 21 dependent Cl 2 channels expressed endogenously in oocytes. Importantly, the extent of curcumin potentiation was enhanced significantly by decreasing ACh concentrations. Curcumin did not alter specific binding of [ 125 I]a-bungarotoxin. In addition, curcumin attenuated nociceptive behavior in both tonic and visceral pain models without affecting motor and locomotor activity and without producing tolerance. Pharmacological and genetic approaches revealed that the antinociceptive effect of curcumin was mediated by a 7 -nACh receptors. Curcumin potentiated the antinociceptive effects of the a 7 -nACh receptor agonist N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU282987). Collectively, our results indicate that curcumin is a positive allosteric modulator of a 7 -nACh receptor and reverses nociception in mouse models of tonic and visceral pain.
|Number of pages||11|
|Journal||Journal of Pharmacology and Experimental Therapeutics|
|Publication status||Published - Apr 2018|
ASJC Scopus subject areas
- Molecular Medicine